Try our mobile app
Screener
Company
Price and
change
Revenue Growth
last / hist
EV /
LTM
EBITDA
(p75)
EV/
Sales
EBITDA LTM
/ Revenue
FCF LTM
/ Revenue
Next GAAP report
Year div-d yield
FCF Yield LTM
-21.1%  /
39.8%
3.2x
10.1x
0.2x
6.1%
-18.2%
..
0.0%
-61.8% 
1.0%  /
26.0%
11.8x
17.3x
1.3x
11.0%
1.2%
2025-05-02
0.0%
1.1% 
16.4%  /
17.8%
4x
11.2x
0.7x
16.8%
7.6%
..
0.0%
78.3% 
-2.1%  /
14.5%
7.2x
9.2x
1x
13.8%
-1.7%
..
5.7%
-2.2% 
5.4%  /
14.1%
3.4x
5.1x
0.4x
11.9%
-18.5%
..
6.5%
-56.5% 
14.1%  /
1.9%
17.7x
17.4x
2.7x
15.5%
-7.2%
..
2.5%
-3.1% 
-0.3%  /
-4.3%
15x
14.1x
2.2x
14.9%
2.8%
..
2.0%
1.6% 
-22.0%  /
-7.5%
>200x
165.5x
0.4x
-8.9%
-7.2%
..
0.0%
-254.2% 
-12.8%  /
-10.0%
10x
8.2x
0.6x
5.8%
-0.1%
2025-05-08
6.1%
-0.3% 
Trending screeners:
@electric-vehicles
@saas
@cannabis-players
@china
Latin America
India
Dividends
@REITs
@adtech
@airlines
@artificial-intelligence
@auto-parts
@cloud-computing
@crypto
@cybersecurity
@e-commerce
@edtech
@finance-and-technology
@gaming
@internet-of-things
@oil-refining
@real-estate-tech
@renewable-energy
@vaccine-makers

Reviews

2025-04-01
#reports #VNRX

[VolitionRx Limited](https://eninvs.com/all.php?name=VNRX) (Diagnostics and Research) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182833)
(2025-03-31, After Market Close):

- Revenue -21.3% YoY (vs +187.9% in previous quarter and historical rate +130.7%)
- EBITDA margin -2857.3% increased compared to -3460.7% same period last year
- Net Debt increased by $2 bln since the start of the year (4035.6% of market cap)
- FCF (LTM) -$15.2 bln (negative), 30299.1% of market cap
- EV/Sales multiple is 1.2x

2025-04-01
#reports #RHE

[Regional Health Properties](https://eninvs.com/all.php?name=RHE) (Medical Care Facilities) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182760)
(2025-04-03):

- Revenue +20% YoY (vs 0.0% in previous quarter and historical rate -3.1%)
- EBITDA margin 16.7% decreased compared to 20.0% same period last year
- Net Debt increased by $5 mln over the past reporting period (101887.3% of market cap)
- FCF (LTM) -$0 bln (negative), 81509.8% of market cap
- EV/EBITDA multiple is 17.5x compared to historical level (75th percentile) of 15x
- EV/Sales multiple is 1.9x

2025-04-01
#reports #REKR

[Rekor Systems](https://eninvs.com/all.php?name=REKR) (Software — Infrastructure) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182793)
(2025-03-31, After Market Close):

- Revenue +18.2% YoY (vs +22.2% in previous quarter and historical rate +55.3%)
- EBITDA margin -138.5% decreased compared to -72.7% same period last year
- Net Debt increased by $6 mln over the past reporting period (13.6% of market cap)
- FCF (LTM) -$0 bln (negative), 9.1% of market cap
- EV/Sales multiple is 1.4x

2025-04-01
#reports #PRGS

[Progress Software](https://eninvs.com/all.php?name=PRGS) (Software provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182758)
(2025-01-21, After Market Close):

- Revenue +28.6% YoY (vs +325.4% in previous quarter and historical rate +28.4%)
- EBITDA +14.5% YoY (vs +530.6% in previous quarter and historical rate +25.4%)
- EBITDA margin 29.8% decreased compared to 33.5% same period last year
- Net Debt decreased by $38 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) -$0.7 bln (negative), 30.5% of market cap
- EV/EBITDA multiple is 8.8x compared to historical level (75th percentile) of 15x
- EV/Sales multiple is 2.7x

At the opening of the session the share price went down -4.2% vs S&P500 +0.6%
2025-04-01
#reports #POLA

[Polar Power](https://eninvs.com/all.php?name=POLA) (Electrical Equipment and Parts) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182783)
(2024-11-15, After Market Close):

- Revenue -25% YoY (vs +150.0% in previous quarter and historical rate +24.9%)
- EBITDA margin -100.0% decreased compared to -75.0% same period last year
- Net Debt decreased by $1 mln over the past reporting period (16.4% of market cap)
- EV/Sales multiple is 0.8x

At the opening of the session the share price went up +599.7% vs S&P500 +0.2%
2025-04-01
#reports #POAI

[Predictive Oncology](https://eninvs.com/all.php?name=POAI) (Medical Instruments and Supplies) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182774)
(2023-05-17, After Market Close):

- Revenue +73.1% YoY (vs -51.6% in previous quarter and historical rate +77.9%)
- EBITDA margin -199.8% increased compared to -991.3% same period last year
- Net Debt increased by $2.4 bln since the start of the year (2142.3% of market cap)
- FCF (LTM) -$5.9 bln (negative), 5293.9% of market cap
- EV/Sales multiple is 0.1x

2025-04-01
#reports #OVLY

[Oak Valley Bancorp](https://eninvs.com/all.php?name=OVLY) (Banks — Regional) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182773)
(2025-01-17, After Market Close):

- Revenue +5.9% YoY (vs 0.0% in previous quarter and historical rate +12.5%)
- Net Income 0% YoY (vs 0.0% in previous quarter and historical rate +38.7%)
- Net Income margin 44.4% decreased compared to 47.1% same period last year
- P/E multiple is 6.4x compared to historical level (75th percentile) of 7.4x
- P/S multiple is 2.9x
- Price to book: 1.1x
2025-04-01
#reports #HCTI

[Healthcare Triangle, Inc.](https://eninvs.com/all.php?name=HCTI) (Health Information Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182808)
(2023-08-07):

- Revenue -71.4% YoY (vs -75.0% in previous quarter and historical rate -20.8%)
- Net Debt increased by $7 mln over the past reporting period (55.8% of market cap)
- FCF (LTM) +$0 bln (positive), 8.0% of market cap
- EV/Sales multiple is 2x

2025-04-01
#reports #FTCI

[FTC Solar, Inc.](https://eninvs.com/all.php?name=FTCI) (Solar) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182805)
(2025-03-12, Before Market Open):

- Revenue -43.5% YoY (vs -67.7% in previous quarter and historical rate -32.8%)
- EBITDA margin -100.0% decreased compared to -47.8% same period last year
- Net Debt increased by $15 mln over the past reporting period (4.0% of market cap)
- FCF (LTM) -$0 bln (negative), 4.5% of market cap
- EV/Sales multiple is 8.1x

At the opening of the session the share price went up +5.9% vs S&P500 +0.9%
2025-04-01
#reports #FBIOP

[Fortress Biotech](https://eninvs.com/all.php?name=FBIOP) (Biotechnology) reported for 2024 q4:

- Revenue -25% YoY (vs -57.1% in previous quarter and historical rate +7.9%)
- EBITDA margin -160.0% increased compared to -500.0% same period last year
- Net Debt increased by $16 mln over the past reporting period (13.5% of market cap)
- FCF (LTM) +$0 bln (positive), 7.6% of market cap
- EV/Sales multiple is 1.9x

2025-04-01
#reports #BW

[Babcock & Wilcox Enterprises](https://eninvs.com/all.php?name=BW) (Specialty Industrial Machinery) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182750)
(2025-03-31, After Market Close):

- Revenue +269.2% YoY (vs -12.1% in previous quarter and historical rate +25.5%)
- EBITDA -250% YoY (vs -200.0% in previous quarter)
- EBITDA margin -0.7% decreased compared to 1.8% same period last year
- Net Debt increased by $139 mln over the past reporting period (232.8% of market cap)
- FCF (LTM) -$0 bln (negative), 63.7% of market cap
- EV/EBITDA multiple is 13.8x compared to historical level (75th percentile) of 55.6x
- EV/Sales multiple is 0.4x

2025-03-30
(review)
Weekly results
for USD strategies

US Leaders: -1.5%

Global Commodities: +0.4%

Trending Ideas: +7.9%

Rising Stars: -2.9%

vs S&P500: -1.5%
2025-03-29
#reports #FF

[FutureFuel](https://eninvs.com/all.php?name=FF) (Chemicals) reported for 2024 q4
(2024-11-08, After Market Close):

- Revenue -32.6% YoY (vs -56.4% in previous quarter and historical rate -1.0%)
- EBITDA -82.6% YoY (vs -133.3% in previous quarter)
- EBITDA margin 6.5% decreased compared to 25.0% same period last year
- Net Debt increased by $23 mln over the past reporting period (12.6% of market cap)
- FCF (LTM) -$0.1 bln (negative), 61.5% of market cap
- EV/EBITDA multiple is 5.5x compared to historical level (75th percentile) of 5.8x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went down -9.5% vs S&P500 +0.2%
2025-03-29
#reports #CLRO

[ClearOne](https://eninvs.com/all.php?name=CLRO) (Communication Equipment) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182690)
(2024-11-15, Before Market Open):

- Revenue -25% YoY (vs -40.0% in previous quarter and historical rate -23.0%)
- EBITDA margin -66.7% decreased compared to -50.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (6.9% of market cap)
- FCF (LTM) -$0 bln (negative), 130.8% of market cap
- EV/Sales multiple is 1.1x

At the opening of the session the share price went down -7.2% vs S&P500 -0.6%
2025-03-29
#reports #CAAS

[China Automotive Systems](https://eninvs.com/all.php?name=CAAS) (Auto Parts) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182688)
(2025-03-28, Before Market Open):

- Revenue +18.9% YoY (vs +18.8% in previous quarter and historical rate +9.8%)
- EBITDA -26.3% YoY (vs +14.3% in previous quarter and historical rate +24.9%)
- EBITDA margin 7.4% decreased compared to 11.9% same period last year
- Net Debt decreased by $53 mln over the past reporting period (36.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 51.3% of market cap
- EV/EBITDA multiple is 0.8x compared to historical level (75th percentile) of 2.4x
- EV/Sales multiple is 0.1x

At the opening of the session the share price went up +1.0% vs S&P500 -0.2%
2025-03-28
#reports #WHLM

[Wilhelmina International](https://eninvs.com/all.php?name=WHLM) (Specialty Business Services) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182637)
(2024-11-18, Before Market Open):

- Revenue 0% YoY (vs +25.0% in previous quarter and historical rate -15.4%)
- P/E multiple is 18x compared to historical level (75th percentile) of 23x
- P/S multiple is 1x
- Price to book: 0.7x

At the opening of the session the share price went down -0.6% vs S&P500 +0.2%
2025-03-28
#reports #WGO

[Winnebago Industries](https://eninvs.com/all.php?name=WGO) (Motorhome manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182634)
(2025-03-27, Before Market Open):

- Revenue -57.7% YoY (vs -18.0% in previous quarter and historical rate +18.5%)
- EBITDA -87.3% YoY (vs -88.9% in previous quarter and historical rate -27.7%)
- EBITDA margin 2.1% decreased compared to 7.0% same period last year
- Net Debt increased by $39 mln over the past reporting period (3.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 10.4% of market cap
- EV/EBITDA multiple is 9.2x compared to historical level (75th percentile) of 6.8x
- EV/Sales multiple is 0.4x

At the opening of the session the share price went up +9.9% vs S&P500 -0.3%
2025-03-28
#reports #SYPR

[Sypris Solutions](https://eninvs.com/all.php?name=SYPR) (Auto Parts) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182630)
(2025-03-24, Before Market Open):

- Revenue -5.7% YoY (vs +5.9% in previous quarter and historical rate +16.1%)
- EBITDA margin 6.1% increased compared to 2.9% same period last year
- Net Debt decreased by $2 mln over the past reporting period (5.6% of market cap)
- FCF (LTM) -$0 bln (negative), 5.6% of market cap
- EV/EBITDA multiple is 7x compared to historical level (75th percentile) of 12.7x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went up +1.8% vs S&P500 +0.9%
2025-03-28
#reports #PRPO

[Precipio](https://eninvs.com/all.php?name=PRPO) (Diagnostics and Research) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182639)
(2023-11-13, After Market Close):

- Revenue +25% YoY (vs 0.0% in previous quarter and historical rate +48.6%)
- EV/Sales multiple is 8.5x

At the opening of the session the share price went down -7.1%
2025-03-28
#reports #MYSZ

[My Size](https://eninvs.com/all.php?name=MYSZ) (Software — Application) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182644)
(2022-11-17):

- Revenue -66.7% YoY (vs 0.0% in previous quarter and historical rate +94.4%)
- EBITDA margin -100.0% decreased compared to -66.7% same period last year
- Net Debt increased by $2 mln over the past reporting period (43.8% of market cap)
- FCF (LTM) -$0 bln (negative), 21.9% of market cap
- EV/Sales multiple is 0.3x

2025-03-28
#reports #IRIX

[IRIDEX Corporation](https://eninvs.com/all.php?name=IRIX) (Medical Devices) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182623)
(2025-03-27, After Market Close):

- Revenue +8.3% YoY (vs -7.7% in previous quarter and historical rate -5.2%)
- Net Debt increased by $1 mln over the past reporting period (6.8% of market cap)
- FCF (LTM) -$0 bln (negative), 34.2% of market cap
- EV/Sales multiple is 0.3x

At the opening of the session the share price went up +16.1% vs S&P500 -0.2%